Robert McNeil
Founder at Sanderling Management CO LLC
Profile
Robert McNeil founded Sanderling Ventures in 1979 and had served since then as a Managing Director of Sanderling’s seven investment partnerships.
Dr. McNeil had been the seed investor for many successful companies including Western Technology Ventures, Advanced Cardiovascular Systems (acquired by Eli Lilly and spun out as Guidant Corp.) and Ventritex (acquired by St. Jude Medical).
Dr. McNeil was the Chairman of Ista Pharmaceuticals, GeminX, as well as other entities.
As an active investor, Dr. McNeil had developed close relationships with management and their technologies, allowing Sanderling to successfully develop products at a very early stage.
Dr. McNeil earned his Ph.D.
in the fields of molecular biology, biochemistry and genetics in 1972 from the University of California, Irvine.
He is also well known for his love of the sea and restoration of important historical vessels.
Robert McNeil active positions
| Companies | Position | Start |
|---|---|---|
Sanderling Management CO LLC
 Sanderling Management CO LLC Investment ManagersFinance Sanderling Management CO LLC (Sanderling Ventures) is a venture capital firm founded in 1979 by Robert G. McNeil. The firm is headquartered in San Mateo, California. | Founder | 1978-12-31 |
Asteres, Inc.
 Asteres, Inc. Industrial MachineryProducer Manufacturing Asteres, Inc. develops secure self-service kiosks for the storage and delivery of prescriptions and consumer products. Its product script center, the prescription pickup kiosk for retail, healthcare and military pharmacies that allows patients to pick up and pay for their prescriptions and other items even when the pharmacy is closed. The company was founded by Linda J. Pinney and John A. Beane in 2003 and is headquartered in San Diego, CA. | Director/Board Member | - |
DalCor Pharmaceuticals Canada, Inc.
 DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology DalCor Pharmaceuticals Canada, Inc. develops precision treatments for cardiovascular diseases. It offers dalcetrapib, a cholesterol ester transfer protein (CETP) inhibitor, as a potential targeted treatment to address the residual cardiovascular risk in patients carrying a specific ADCY9 genetic profile. The company was founded by Andr? Roger Desmarais and is headquartered in Montreal, Canada. | Director/Board Member | 2019-02-26 |
Therillia Development Co., Inc.
 Therillia Development Co., Inc. Pharmaceuticals: MajorHealth Technology Therillia Development Co., Inc. operates as a portfolio company of Sanderling Ventures. It develops novel drug candidates of interest to Sanderling and other venture capital investors from preclinical to clinical proof of concept. The company is headquartered in Montreal, Canada. | Director/Board Member | - |
Diazon Pharmaceuticals, Inc.
 Diazon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diazon Pharmaceuticals, Inc. engages in the development of the onco-therapeutic DZ-2384 that targets a proven therapeutic pathway in oncology. The company was founded by Anne Roulston, Gordon Shore and Patrick Harran in 2013 and is headquartered in Montreal, Canada. | Chairman | - |
Former positions of Robert McNeil
| Companies | Position | End |
|---|---|---|
| REGEN BIOLOGICS INC. | Chief Executive Officer | 2011-03-03 |
| RBio, Inc. | Director/Board Member | 2001-12-31 |
NRB, Inc.
 NRB, Inc. Engineering & ConstructionIndustrial Services NRB, Inc. operates as a modular construction company which designs and manufactures modular buildings. The company was founded by Jean Doreen McNeil and Robert George McNeil in 1979 and is headquartered in Grimsby, Canada. | Founder | - |
San Francisco Investment SA
 San Francisco Investment SA Media ConglomeratesConsumer Services Part of Sun International Ltd., San Francisco Investment SA operates casinos. The private company is based in San Francisco De Mostazal, Chile. San Francisco Investment was acquired by Sun International Ltd. on December 01, 2014 for $113.98 million. | Corporate Officer/Principal | - |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
Training of Robert McNeil
| University of California, Irvine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| AVID BIOSERVICES, INC. | Health Technology |
| REGEN BIOLOGICS INC. | Health Services |
| STEREOTAXIS, INC. | Health Technology |
| Private companies | 17 |
|---|---|
CoCensys, Inc.
 CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | Health Technology |
ISTA Pharmaceuticals, Inc.
 ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Health Technology |
Sanderling Management CO LLC
Sanderling Management CO LLC Investment ManagersFinance Sanderling Management CO LLC (Sanderling Ventures) is a venture capital firm founded in 1979 by Robert G. McNeil. The firm is headquartered in San Mateo, California. | Finance |
Infraredx, Inc.
 Infraredx, Inc. Medical SpecialtiesHealth Technology Infraredx, Inc. is a developed cardiovascular imaging devices. Its product were TVC Imaging System dual-modality intravascular imaging system with the ability to assess vessel structure and plaque composition via integrated NIRS near infrared spectroscopy lipid-core plaque LCP detection and enhanced IVUS imaging technology. The company was founded by James E. Muller in 1999 and was headquartered in Bedford, MA. | Health Technology |
Asteres, Inc.
Asteres, Inc. Industrial MachineryProducer Manufacturing Asteres, Inc. develops secure self-service kiosks for the storage and delivery of prescriptions and consumer products. Its product script center, the prescription pickup kiosk for retail, healthcare and military pharmacies that allows patients to pick up and pay for their prescriptions and other items even when the pharmacy is closed. The company was founded by Linda J. Pinney and John A. Beane in 2003 and is headquartered in San Diego, CA. | Producer Manufacturing |
Tomophase, Inc.
 Tomophase, Inc. Medical SpecialtiesHealth Technology Tomophase, Inc. develops diagnostic imaging solutions. Its products includes respiratory tract, reproductive tract and gastrointestinal tract. The company was founded by Peter E. Norris, Xiao-li Li and Feiling Wang in 2003 and is headquartered in Cambridge, MA. | Health Technology |
ACEA Biosciences, Inc.
 ACEA Biosciences, Inc. BiotechnologyHealth Technology ACEA Biosciences, Inc. develops bio-sensor platform based on microelectronic technologies. The firm pioneers in development and commercialization of innovative cell analysis instrumentation for life sciences, and is also engaged in drug discovery and pharmaceutical development. Its xCELLigence impedance-based, label-free, real-time cell analysis systems and NovoCyte benchtop flow cytometers are used in preclinical drug discovery and development, toxicology, safety pharmacology, disease studies, and basic academic research. The company was founded in 2002 and is headquartered in San Diego, CA. | Health Technology |
Kadmus Pharmaceuticals, Inc.
 Kadmus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kadmus Pharmaceuticals, Inc. manufactures and sells biopharmaceutical products. It develops and commercializes proprietary molecules targeting critical pathways contributing to pain, disorders of the nervous system, and other unmet medical needs. The firm also performs formulation, pre-clinical development and also oversees the manufacturing, preclinical toxicology, and clinical development of candidate drugs via a key vendor network. Kadmus Pharmaceuticals was founded in 1998 and is headquartered in Irvine, CA. | Health Technology |
Gemin X Pharmaceuticals US, Inc.
 Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Health Technology |
CoMentis, Inc.
 CoMentis, Inc. Pharmaceuticals: MajorHealth Technology CoMentis, Inc. focuses on developing drugs to treat various central nervous system disorders. Its research and development spectrum include BACE inhibitors and modulators of the a7 nicotinic acetylcholine receptor (NAChR). The company was founded by John P. Cooke and Muralitharan Kengatharan in 2006 and is headquartered in South San Francisco, CA. | Health Technology |
San Francisco Investment SA
San Francisco Investment SA Media ConglomeratesConsumer Services Part of Sun International Ltd., San Francisco Investment SA operates casinos. The private company is based in San Francisco De Mostazal, Chile. San Francisco Investment was acquired by Sun International Ltd. on December 01, 2014 for $113.98 million. | Consumer Services |
| RBio, Inc. | |
| Shuman, Agnew & Co. | Finance |
NRB, Inc.
NRB, Inc. Engineering & ConstructionIndustrial Services NRB, Inc. operates as a modular construction company which designs and manufactures modular buildings. The company was founded by Jean Doreen McNeil and Robert George McNeil in 1979 and is headquartered in Grimsby, Canada. | Industrial Services |
Therillia Development Co., Inc.
Therillia Development Co., Inc. Pharmaceuticals: MajorHealth Technology Therillia Development Co., Inc. operates as a portfolio company of Sanderling Ventures. It develops novel drug candidates of interest to Sanderling and other venture capital investors from preclinical to clinical proof of concept. The company is headquartered in Montreal, Canada. | Health Technology |
DalCor Pharmaceuticals Canada, Inc.
DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology DalCor Pharmaceuticals Canada, Inc. develops precision treatments for cardiovascular diseases. It offers dalcetrapib, a cholesterol ester transfer protein (CETP) inhibitor, as a potential targeted treatment to address the residual cardiovascular risk in patients carrying a specific ADCY9 genetic profile. The company was founded by Andr? Roger Desmarais and is headquartered in Montreal, Canada. | Health Technology |
Diazon Pharmaceuticals, Inc.
Diazon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diazon Pharmaceuticals, Inc. engages in the development of the onco-therapeutic DZ-2384 that targets a proven therapeutic pathway in oncology. The company was founded by Anne Roulston, Gordon Shore and Patrick Harran in 2013 and is headquartered in Montreal, Canada. | Health Technology |
- Stock Market
- Insiders
- Robert McNeil
